Which anti-inflammatory medication is commonly used to decrease ICP?

Decadron, which is a brand name for dexamethasone, is a corticosteroid that is often used to decrease intracranial pressure (ICP). This medication works by reducing inflammation and suppressing the immune response, which can be particularly important in conditions that lead to increased ICP, such as brain tumors, traumatic brain injury, or certain infections.

When given, Decadron helps to minimize the swelling and edema around the brain, thereby reducing pressure within the cranial cavity. This property makes it a critical medication in managing patients with a risk of elevated ICP.

While ibuprofen and aspirin are non-steroidal anti-inflammatory drugs (NSAIDs) primarily used for pain relief and reducing inflammation, they are not typically indicated for decreasing ICP. Prednisone, like Decadron, is also a corticosteroid but is less commonly used for acute management of ICP compared to dexamethasone. Therefore, Decadron is the most appropriate choice in this context.